Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
ABSTRACT Introduction The Coronavirus Disease 2019 (COVID-19) pandemic has caused
devastating human and economic costs. Vaccination is an important step in controlling the …
devastating human and economic costs. Vaccination is an important step in controlling the …
Glycosylated Delta-receptor-binding domain mucosal vaccine elicits broadly neutralizing antibodies with protection against SARS-CoV-2 challenge
Mucosal COVID-19 vaccines are needed to block SARS-CoV-2 infection at the mucosal site.
Intranasal delivery of a glycosylated Delta variant receptor-binding domain (Delta-RBD) …
Intranasal delivery of a glycosylated Delta variant receptor-binding domain (Delta-RBD) …
Screening of efficient adjuvants for the RBD-based subunit vaccine of SARS-CoV-2
J Shi, Y Zhao, M Peng, S Zhu, Y Wu, R Ji, C Shen - Vaccines, 2023 - mdpi.com
The variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are more
transmissible, with a reduced sensitivity to vaccines targeting the original virus strain …
transmissible, with a reduced sensitivity to vaccines targeting the original virus strain …
[HTML][HTML] MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection
Middle East respiratory syndrome coronavirus (MERS-CoV), a highly pathogenic
coronavirus in the same Betacoronavirus genus and Coronaviridae family as SARS-CoV-2 …
coronavirus in the same Betacoronavirus genus and Coronaviridae family as SARS-CoV-2 …
Safety and immunogenicity following the second and third doses of the BNT162b2 mRNA COVID-19 vaccine in adolescents with juvenile-onset autoimmune …
M Heshin-Bekenstein, A Ziv, N Toplak, S Lazauskas… - Vaccines, 2023 - mdpi.com
Background: To explore the long-term safety and dynamics of the immune response induced
by the second and third doses of the BNT162b2 mRNA COVID-19 vaccine in adolescents …
by the second and third doses of the BNT162b2 mRNA COVID-19 vaccine in adolescents …
[HTML][HTML] AT cell–based SARS-CoV-2 spike protein vaccine provides protection without antibodies
Abstract SARS-CoV-2 spike–based vaccines are used to control the COVID-19 pandemic.
However, emerging variants have become resistant to antibody neutralization and further …
However, emerging variants have become resistant to antibody neutralization and further …
A Unique mRNA Vaccine Elicits Protective Efficacy against the SARS-CoV-2 Omicron Variant and SARS-CoV
The highly pathogenic coronaviruses SARS-CoV-2 and SARS-CoV have led to the COVID-
19 pandemic and SARS outbreak, respectively. The receptor-binding domain (RBD) of the …
19 pandemic and SARS outbreak, respectively. The receptor-binding domain (RBD) of the …
[PDF][PDF] Factores que influyen en la respuesta de anticuerpos neutralizantes al virus SARS-CoV-2 original y su variante Ómicron, un estudio basado en la población.
J Hormazabal - congreso2023.ufro.cl
Presentación de PowerPoint Page 1 Factores que influyen en la respuesta de anticuerpos
neutralizantes al virus SARSCoV-2 original y su variante Ómicron, un estudio basado en la …
neutralizantes al virus SARSCoV-2 original y su variante Ómicron, un estudio basado en la …
[HTML][HTML] Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a …
J Hormazábal, L Nuñez-Franz, P Rubilar, M Apablaza… - Vaccine: X, 2023 - Elsevier
Objective The study compared immunity to the original SARS-CoV-2 virus (Wuhan) and the
Omicron variant using neutralizing antibodies (NAbs), that provide a good approximation of …
Omicron variant using neutralizing antibodies (NAbs), that provide a good approximation of …